Related references
Note: Only part of the references are listed.IL-38-mediated NLRP3/caspase-1 inhibition is a disease-modifying treatment for TMJ inflammation
Ping Luo et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2022)
IL-36 gamma and IL-36Ra Reciprocally Regulate Colon Inflammation and Tumorigenesis by Modulating the Cell-Matrix Adhesion Network and Wnt Signaling
Wei Yang et al.
ADVANCED SCIENCE (2022)
NLRP3 Inflammasome Inhibitor OLT1177 Suppresses Onset of Inflammation in Mice with Dextran Sulfate Sodium-Induced Colitis
Tomofumi Oizumi et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development
Lingli Zhou et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease
Dennis M. de Graaf et al.
CYTOKINE (2021)
Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects
Dennis M. de Graaf et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats
Sameh Saber et al.
LIFE SCIENCES (2021)
Interleukin-38 in colorectal cancer: a potential role in precision medicine
Feier Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation
Cheng Xie et al.
CYTOKINE (2020)
The microbiome and inflammatory bowel disease
Kerri L. Glassner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Emerging treatments for inflammatory bowel disease
Karl Hazel et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Focus on the Role of NLRP3 Inflammasome in Diseases
Roberta Fusco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells
Fang Bian et al.
FRONTIERS IN PHARMACOLOGY (2019)
Innate immunity to intracellular LPS
Vijay A. K. Rathinam et al.
NATURE IMMUNOLOGY (2019)
IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells
Yingying Han et al.
CELL REPORTS (2019)
IL-38: A New Player in Inflammatory Autoimmune Disorders
Lihui Xie et al.
BIOMOLECULES (2019)
Mendelian randomization analysis of C-reactive protein on colorectal cancer risk
Xiaoliang Wang et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Neutralization of IL-1α ameliorates Crohn's disease-like ileitis by functional alterations of the gut microbiome
Paola Menghini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling
Xueliang Chen et al.
CELL DEATH & DISEASE (2019)
Colorectal Cancer in Inflammatory Bowel Disease
Ryan W. Stidham et al.
CLINICS IN COLON AND RECTAL SURGERY (2018)
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
Laura Mercurio et al.
CELL DEATH & DISEASE (2018)
Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease
Gabriela Fonseca-Camarillo et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Inflammatory cell death in intestinal pathologies
Deepika Sharma et al.
IMMUNOLOGICAL REVIEWS (2017)
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage
Oscar Medina-Contreras et al.
JOURNAL OF IMMUNOLOGY (2016)
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease
M. -A. Boutet et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
IL-36 Receptor Is Required for Resolution of Intestinal Damage
Akihito Harusato et al.
INFLAMMATORY BOWEL DISEASES (2016)
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation
S. E. Russell et al.
MUCOSAL IMMUNOLOGY (2016)
Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice
Marina Bersudsky et al.
GUT (2014)
NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population
Hong-xin Zhang et al.
INFLAMMATION RESEARCH (2014)
Paneth cells as a site of origin for intestinal inflammation
Timon E. Adolph et al.
NATURE (2013)
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells
Margherita Coccia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
Frank L. van de Veerdonk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Janice J. Kim et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Christian Bauer et al.
GUT (2010)
The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
Md. Hasan Zaki et al.
IMMUNITY (2010)
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
Alexandra-Chloe Villani et al.
NATURE GENETICS (2009)
The NLR gene family: A standard nomenclature
Jenny P. -Y. Ting et al.
IMMUNITY (2008)
Intracellular NOD-like receptors in host Defense and disease
Thirumala-Devi Kanneganti et al.
IMMUNITY (2007)
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
Philippe Goyette et al.
ANNALS OF MEDICINE (2007)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk
MD Rutter et al.
GUT (2004)
Increased expression of interleukin 17 in inflammatory bowel disease
S Fujino et al.
GUT (2003)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cloning and characterization of IL-1HY2, a novel interleukin-1 family member
HS Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
